Division of Dermatology, Rabin Medical Center (Beilinson Hospital), Petah Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Int J Dermatol. 2021 Mar;60(3):321-326. doi: 10.1111/ijd.15319. Epub 2020 Nov 25.
Hidradenitis suppurativa (HS) is a chronic inflammatory disease involving the skin bearing apocrine glands. There are numerous comorbidities and associated diseases among patients with HS. The association of HS and thyroid abnormalities is equivocal. We aimed to explore whether HS is associated with thyroid disorders.
In this cross-sectional large-scale population-based study in Israel, patients with a validated diagnosis of HS were matched at a proportion of 1:5 with age- and gender-matched healthy controls without HS. A cross-checking for HS diagnosis by International Classification of Diseases, ninth revision (ICD-9) coding, and hyperthyroidism and hypothyroidism by ICD-9 coding was performed. Demographic and exposure covariates were identified. Univariate and multivariate logistic regressions were utilized to establish the association of HS with thyroid disorders.
Study participants included 4,191 HS patients and 20,941 controls. The average age of patients was 39.7 years old, and 61.8% were female. 53.4% of HS patients and 13.5% of controls (P < 0.001) were smokers. Odds ratios (ORs) for hypothyroidism and hyperthyroidism in HS were 2.91 (95% confidence interval [CI] 2.48-3.40) and 2.25 (95% CI 1.55-3.28), respectively (P < 0.001 for both). While the association of HS with hypothyroidism was maintained across genders and all age groups, and remained positive after controlling for smoking status, the association with hyperthyroidism remained positive only among females, middle-aged patients, and nonsmokers.
HS is independently associated with hypothyroidism. The association of HS with hyperthyroidism held significance only in limited subgroups. Smoking status is a major modifier, mainly in the association of HS with hyperthyroidism.
化脓性汗腺炎(HS)是一种涉及顶泌腺的慢性炎症性疾病。HS 患者存在众多合并症和相关疾病。HS 与甲状腺异常之间的关联尚无定论。我们旨在探究 HS 是否与甲状腺疾病相关。
本研究在以色列开展了一项基于人群的大型横断面研究,对经验证的 HS 患者按照年龄和性别 1:5 的比例与无 HS 的健康对照者进行匹配。通过国际疾病分类第 9 版(ICD-9)编码对 HS 诊断进行交叉检查,并通过 ICD-9 编码检查甲状腺功能亢进和甲状腺功能减退。确定了人口统计学和暴露因素的协变量。采用单变量和多变量逻辑回归来确定 HS 与甲状腺疾病之间的关联。
研究纳入了 4191 例 HS 患者和 20941 例对照者。患者的平均年龄为 39.7 岁,61.8%为女性。53.4%的 HS 患者和 13.5%的对照者(P<0.001)为吸烟者。HS 患者发生甲状腺功能减退和甲状腺功能亢进的比值比(OR)分别为 2.91(95%置信区间 [CI] 2.48-3.40)和 2.25(95% CI 1.55-3.28)(均 P<0.001)。HS 与甲状腺功能减退的相关性在性别和所有年龄组中均保持一致,且在控制吸烟状况后仍为阳性,而与甲状腺功能亢进的相关性仅在女性、中年患者和不吸烟者中为阳性。
HS 与甲状腺功能减退独立相关。HS 与甲状腺功能亢进的相关性仅在有限的亚组中具有统计学意义。吸烟状况是一个主要的修饰因素,主要影响 HS 与甲状腺功能亢进的相关性。